Neovacs S.A.
Records under this name other than patents Neovacs S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Neovacs S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,208,148 | Chemically modified cytokines Term ended Term ended Jul 9, 2020 · USPTO record | Term ended | Term ended Jul 9, 2020 | USPTO record |
| US 7,067,246 | Method for determining prognosis of HIV infected individuals Lapsed on the fee record Ended Jun 27, 2014 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2014 | USPTO record |